Pursue an alternative to current treatments.

Metavention Clinical Study Person Mobile Hero Clinical Studies

You can effect real change.

Metavention is conducting clinical studies evaluating the safety and performance of hepatic denervation in patients with metabolic disease. If you or someone you care about is interested in pursuing an alternative to current treatments, answer the questions below and click on Am I A Candidate to take the next step.

USA Map 01

DeLIVER - U.S. Study

The DeLIVER U.S. Study is a feasibility study evaluating the safety and performance of hepatic denervation with Metavention’s iRF Denervation System for the treatment of type 2 diabetes. This study is currently enrolling patients in the United States and has been approved by the U.S. Food and Drug Administration (FDA).

To learn more about this study and see a list of participating research centers, please visit ClinicalTrials.gov

Am I a candidate for the DeLIVER U.S. study?

Do you have type 2 diabetes and...

  • Are between the ages of 22 and 65?
  • Have high blood pressure?
  • Currently take two or more medications for your type 2 diabetes but would be interested in trying an alternative to new medication?

IF YOU ANSWERED “YES” TO ANY OF THESE QUESTIONS, YOU MAY BE ELIGIBLE TO PARTICIPATE IN THE DeLIVER U.S. CLINICAL STUDY.

Am I a Candidate?
NZ Map 01

DeLIVER - NZ Study

The DeLIVER NZ Study is a feasibility study evaluating the safety and performance of hepatic denervation using Metavention’s iRF Denervation System for the treatment of type 2 diabetes. This study is currently enrolling patients in New Zealand and has been approved by the New Zealand Health and Disability Ethics Committee (HDEC).

To learn more about this study, please visit anzctr.org.au.

Am I a candidate for this DeLIVER NZ study?

Do you have type 2 diabetes and...

  • Are between the ages of 22 and 65?
  • Are currently taking metformin for your type 2 diabetes but you would be interested in trying an alternative to new medication?
  • Have high blood pressure?

IF YOU ANSWERED “YES” TO ANY OF THESE QUESTIONS, YOU MAY BE ELIGIBLE TO PARTICIPATE IN THE DeLIVER NZ CLINICAL STUDY.

AUS Map 01

MODUS Study - Australia

The MODUS Study is a randomized feasibility study evaluating the safety and performance of hepatic (liver) denervation, renal (kidney) denervation or multi-organ (liver and kidney) denervation with Metavention’s iRF Denervation System for the treatment of type 2 diabetes and high blood pressure. Participants will receive one of these denervation treatments but will not know which one. This study is currently enrolling patients in Australia and has been approved by the Human Research Ethics Committee (HREC/60968/Alfred-2020).

To learn more about this study, please visit anzctr.org.au.

Am I a candidate for MODUS study?

Do you have type 2 diabetes, high blood pressure, and...

  • Are between the ages of 22 and 70?
  • Are currently taking medication for your type 2 diabetes and high blood pressure but you would be interested in trying an alternative to medication?
  • Would you be willing to discontinue or change your current diabetes and blood pressure medications if you were closely supervised?

IF YOU ANSWERED, “YES” TO ANY OF THESE QUESTIONS, YOU MAY BE ELIGIBLE TO PARTICIPATE IN THE MODUS CLINICAL STUDY.

Why Participate?

Choosing to participate in a research study is an important personal decision. People who participate in clinical trials:

  • Have access to treatments that may not be available to the public
  • Play an active role in their own healthcare
  • Help find treatments to improve the quality of life for people with a specific disease
  • Often receive more attention than routine care allows

If you are interested in learning more about clinical studies, discuss the possible risks and benefits with your doctor.